The Inconsistent and Inadequate Reporting Of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials.

MLA

Tong Xie, et al. “The Inconsistent and Inadequate Reporting Of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials.” Oncologist, vol. 26, no. 12, Dec. 2021, pp. e2239–46. EBSCOhost, https://doi.org/10.1002/onco.13940.

APA

Tong Xie, Zhening Zhang, Changsong Qi, Ming Lu, Xiaotian Zhang, Jian Li, Lin Shen, & Zhi Peng. (2021). The Inconsistent and Inadequate Reporting Of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials. Oncologist, 26(12), e2239–e2246. https://doi.org/10.1002/onco.13940

Chicago

Tong Xie, Zhening Zhang, Changsong Qi, Ming Lu, Xiaotian Zhang, Jian Li, Lin Shen, and Zhi Peng. 2021. “The Inconsistent and Inadequate Reporting Of Immune-Related Adverse Events in PD-1/PD-L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials.” Oncologist 26 (12): e2239–46. doi:10.1002/onco.13940.